Supernus Pharmaceuticals, Inc. (SUPN)
After hours:
| Previous close | 29.71 |
| Open | 29.75 |
| Bid | 29.89 x 200 |
| Ask | 30.41 x 400 |
| Day's range | 29.59 - 31.84 |
| 52-week range | 21.99 - 38.09 |
| Volume | |
| Avg. volume | 393,080 |
| Market cap | 1.639B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | 1,497.50 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you want to skip our overview of the global pharmaceutical and healthcare industry, which is one the most unique sectors in the world, then you can check out 5 Best Small Cap Pharma Stocks to […]
- Simply Wall St.
Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
Supernus Pharmaceuticals ( NASDAQ:SUPN ) Full Year 2023 Results Key Financial Results Revenue: US$607.5m (down 8.9...
- Insider Monkey
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript February 27, 2024 Supernus Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to the Supernus Pharmaceuticals’ Fourth Quarter and Full Year 2023 Financial Results Conference […]
